PS-QD Phase3 Clinical Study -Investigation to find new dosage and administration of mesalazine for the treatment of patients with Ulcerative Colitis in remission phase.- PS-QDPhase3 Clinical Study -Investigation to find new dosage and administration of mesalazine for th ...
PS-QD Phase3 Clinical Study -Investigation to find new dosage and administration of mesalazine for the treatment of patients with Ulcerative Colitis in remission phase.- PS-QDPhase3 Clinical Study -Investigation to find new dosage and administration of mesalazine for th ...
ulcerative colitis
Intervention name : PS-QD Dosage And administration of the intervention : Mesalazine at the dose 1500mg/day or 2250mg/day is administered once a day or three times a day. Control intervention name : null Intervention name : PS-QD Dosage And administration of the intervention : Mesalazine at the dose 1500 ...